| 从灵芝类保健食品批准情况看未来中药类保健食品发展方向 |
| 投稿时间：2020-05-19 点此下载全文
|
| 引用本文：萨翼.从灵芝类保健食品批准情况看未来中药类保健食品发展方向[J].中国现代中药,2020,22(7):1124-1129 |
| DOI： |
| 摘要点击次数: 735 |
| 全文下载次数: 364 |
|
|
| 基金项目:国家市场监督管理总局《可用于保健食品物品名单》修订研究项目 |
|
| 中文摘要:灵芝在中国有近千年的使用历史，在传统中药中被列为上品，其养生保健作用被历代医家认可。近年来，灵芝可用部位不断被挖掘，在保健食品中的可用部位原料包括灵芝子实体、灵芝孢子粉、灵芝孢子油和灵芝菌丝体。截至2018年底，已批准含有上述可用部位的保健食品数量达到1270余个。本研究首次系统地对1997年以来批准的灵芝类保健食品进行分类梳理总结。首先对每个可用部位的单方和复方产品批准情况分别统计；再对灵芝传统使用部位的复方保健食品配方配伍进行分析；最后以灵芝为例，分析了已批准中药类保健食品的现状，提出未来中药类保健食品发展方向。 |
| 中文关键词:灵芝 中药类保健食品 监督管理 灵芝孢子粉 灵芝孢子油 |
| |
| Development Trend of Traditional Chinese Medicine Dietary Supplement from Approval of Ganoderma Dietary Supplements |
|
|
| Abstract:Ganoderma has a history of thousands of years in China，and it is classified as top grade in traditional Chinese medicine. The health-preserving and health-care functions of Ganoderma have been recognized by doctors of all ages. The usable parts of Ganoderma including fruiting body，Ganoderma lucidum spore powder，G. lucidum spore oil and Ganoderma lucidum mycelium，are continuously excavated. The number of approval health foods containing usable parts has reached more than 1270 by the end of 2018. This article is the first systematic classification and summary of Ganoderma health food approved since 1997. First of all，each available part of the unilateral and compound product approval were respectively statistically reviewed，and then the compatibility of the compound dietary supplement of Lingzhi mushroom′s traditionally used parts was analyzed. Finally，taking Ganoderma as an example，the current situation of approved Chinese medicine dietary supplement is analyzed，and the future development direction of Chinese medicine dietary supplement was put forward. |
| keywords:Ganoderma Chinese medicine dietary supplement supervision and management Ganoderma spore powder Ganoderma spore oil |
|
查看全文
查看/发表评论 下载PDF阅读器 |
